Patient Assistance Program: New Eylea 4U

Introducing the new patient assistance program – New Eylea 4U! This program aims to improve adherence to the treatment and to reduce the treatment burden for patients. Adherence is crucial in wAMD and DME treatment as non-adherence can lead to severe vision impairments. However, due to different issues like limited income and lack of support, adherence to treatments remains a major issue in the treatment of wAMD and DME. By enrolling in New Eylea 4U, patients can get 14 Eylea injections at the cost of five Eylea injections only, in which the cost per injection would be less than some of the available anti-VEGFs.